| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9328426 | Gynecologic Oncology | 2005 | 5 Pages |
Abstract
In this study the combination of docetaxel plus cisplatin was considerably more active in vitro than any of the other taxane plus platinum agent combinations evaluated in the panel of human ovarian cancer cell lines. In vitro activity was similar to previously report clinical studies comparing taxane and platinum combination regimens. This suggests the combination of docetaxel with cisplatin will have enhanced clinical activity compared to the paclitaxel plus carboplatin regimen.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Judith A. Smith, Hop Ngo, Miranda C. Martin, Judith K. Wolf,